Metformin and thymoquinone synergistically inhibit proliferation of imatinib-resistant human leukemic cells

U Glamoclija, L Mahmutovic, E Bilajac… - Frontiers in …, 2022 - frontiersin.org
Chemotherapy resistance is one of the major challenges in cancer treatment, including
leukemia. A massive array of research is evaluating combinations of drugs directed against …

An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

Y Chen, Q Gao, D Wang, X Zou, X Li, J Ji… - Current Drug …, 2025 - benthamdirect.com
This review provides a comprehensive overview of the recent advancements in research on
ATF4 (Activating Transcription Factor 4) within the field of oncology. As a crucial transcription …

Curcumin decreases viability and inhibits proliferation of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cell lines

E Bilajac, L Mahmutović, U Glamočlija, A Osmanović… - Metabolites, 2022 - mdpi.com
Chronic myeloid leukemia (CML) is a myeloproliferative haematological malignancy
characterized by constitutive activation of BCR-ABL1 tyrosine kinase in the majority of …

ER stress modulates Kv1. 5 channels via PERK branch in HL-1 atrial myocytes: Relevance to atrial arrhythmogenesis and the effect of tetramethylpyrazine

XC Wang, Y Zhou, HX Chen, HT Hou, GW He, Q Yang - Heliyon, 2024 - cell.com
Endoplasmic reticulum (ER) stress is implicated in cardiac arrhythmia whereas the
associated mechanisms remain inadequately understood. Kv1. 5 channels are essential for …

Knockdown of NUPR1 enhances the sensitivity of non-small-cell lung cancer cells to metformin by AKT inhibition

YJ Kim, SE Hong, SK Jang, KS Park, CH Kim… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Metformin is a widely used drug for type 2 diabetes mellitus and has
recently attracted broad attention for its therapeutic effects on many cancers. This study …

Metabolic and metabolomic effects of metformin in murine model of pulmonary adenoma formation

AC Elton, V Cedarstrom, A Quraishi, B Wuertz… - Nutrition and …, 2023 - Taylor & Francis
Epidemiologic studies of diabetic patients treated with metformin identified significantly
lower incidences of cancer. From this, there is growing interest in the use of metformin to …

Mining the biomarkers and associated-drugs for esophageal squamous cell carcinoma by bioinformatic methods

X Kuang, Z Liu - The Tohoku Journal of Experimental Medicine, 2022 - jstage.jst.go.jp
Esophageal squamous cell carcinoma (ESCC) showed limited treatment outcome and poor
prognosis. This study aimed to screen potential biomarkers and drugs in ESCC. Firstly …

[PDF][PDF] THE ROLE OF METFORMIN IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER

J Ljubicic, A Pesic, K Pavlovic… - ZDRAVSTVENA …, 2022 - komorazus.org.rs
Out of the all newly diagnosed lung cancers, non-small cell lung carcinoma (NSCLC)
comprises 80-85%. When treating advanced stages of the disease, conventional therapy …

ULOGA METFORMINA U TERAPIJI NESITNOĆELIJSKOG KARCINOMA PLUĆA

J Ljubičič, A Pešić, K Pavlović, SM Denčić… - Zdravstvena …, 2022 - aseestant.ceon.rs
Sažetak Nesitnoćelijski karcinom pluća (NSCLC) sačinjava 80-85% svih dijagnostikovanih
formi karcinoma pluća. Konvencionalni terapijski modaliteti pokazuju malu uspešnost u …

The role of metformin in the treatment of non-small cell lung cancer

J Ljubičić, A Pešić, K Pavlović, DS Misirlić… - Zdravstvena …, 2022 - data-scindeks.ceon.rs
Out of the all newly diagnosed lung cancers, non-small cell lung carcinoma (NSCLC)
comprises 80-85%. When treating advanced stages of the disease, conventional therapy …